{{header-clinical-trials-navigation}}

A Phase 2 Comparison Study of 68Ga-PSMA-HBED-CC Positron Emission Tomography (PET)/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer


Condition: Prostate Cancer

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT03439033

Sponsor: Weill Medical College of Cornell University

Phase: Phase 2

Eligibility:

  • Age: minimum 21 Years maximum N/A
  • Gender: Male

Exclusion Criteria:

  1. Clinical and/or technical factors that would compromise statistical analysis of the PET and/or MRI.
  2. If part of PET/MRI cohort and patient cohort 3 or 5, subject does not plan to have a prescribed abdomen and pelvis MRI
  3. If part of PET/MRI cohort and patient cohort 1, 2 or 4, subject does not plan to have a prescribed pelvis MRI
  4. If part of PET/CT cohort and patient cohort 3 or 5, subject does not have previous MR imaging of abdomen and pelvis
  5. If part of PET/CT cohort and patient cohort 1, 2 or 4, subject does not have previous MR imaging of pelvis
  6. If part of PET/CT cohort, investigator review determines that previous MR images do not meet institutional quality standards
  7. If part of PET/MRI cohort, contraindications to MRI
  8. Contraindications to PSMA IV administration
  9. Other unspecified reasons that, in the opinion of investigators, make the subject unsuitable for enrollment

View trial on ClinicalTrials.gov


{{footer-clinical-trials-navigation}}
X